Aurinia Pharmaceuticals to Release Third Quarter 2021 Financial Results on November 3, 2021
October 27 2021 - 7:07AM
Business Wire
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”)
today announced that it will release its third quarter 2021
financial results on Wednesday, November 3, 2021, before the
markets open. Aurinia’s management team will also host a conference
call at 8:30 a.m. ET to discuss the Company’s financial results and
provide general operational and business updates.
The conference call and webcast is scheduled for November 3,
2021 8:30 a.m. ET. To participate in the conference call,
please dial +1-877-407-9170 (Toll-free U.S. & Canada). An audio
webcast can be accessed under "News/Events” through the “Investors”
section of the Aurinia corporate website at www.auriniapharma.com.
A replay of the webcast will be available on Aurinia’s website.
ABOUT AURINIA
Aurinia Pharmaceuticals is a fully integrated biopharmaceutical
company focused on delivering therapies to treat targeted patient
populations that are impacted by serious diseases with a high unmet
medical need. The Company has introduced LUPKYNIS™ (voclosporin),
the first FDA-approved oral therapy indicated for the treatment of
adult patients with active lupus nephritis (LN). The Company’s head
office is in Victoria, British Columbia, its U.S. commercial hub is
in Rockville, Maryland, and the Company focuses its development
efforts globally.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211027005062/en/
Dana Lynch, Corporate Communications & IR
IR@auriniapharma.com
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Apr 2023 to Apr 2024